R&D Pipeline News - Therapeutic Area Edition: 1-Yr Subscription

Publisher: La Merie Publishing
Format: PDF
Type: Weekly e-mail delivery
Product Code: LMPE0002
Release Date: October of 2005

900.00 €
Free of 21 % VAT (except in Spain and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product

R&D Pipeline News – Therapeutic Area Edition: 1-Year Subscription

R&D Pipeline News is a weekly delivered information tool summarizing in a tabular format

  • press releases about biopharmaceutical R&D of the previous week;
  • business deals (collaboration, licensing, M&A);
  • company R&D Pipelines;
  • target or technology pipelines.

The information is provided in an easy- and rapid-to-screen tabular format. Hyperlinks lead to the original source of information, e.g. the press release. The pdf document is sent by e-mail directly to your desktop.


R&D Pipeline News is available in two editions:

  • Technology edition: news are sorted by Product Category (antibody, protein, small molecule…);
  • Therapeutic Area edition: e.g. Cardiovascular, Dermatology, Infectious, Oncology…

The tabular format and sorting by technology or therapeutic area saves your time for selecting only those news of interest for you.

Key Product Features

  • News filtered by expert editorial to focus on concise and factual information;
  • News presented in a structured format for rapid selection of relevant information;
  • Brief textual summary of news and hyperlink to read original and full length press release;
  • Business deals are described in a systematic manners;
  • Desktop delivery to individual e-mail accounts for access 24/7 everywhere;
  • PDF format allows storage and recovery of information;
  • 50 editions per year with 50 target pipelines and more than 100 company pipelines;
  • Target pipelines are a selection of our competitor analysis reports with a focus on antibodies, proteins, vaccines, biosimilars, oncology and inflammation.

Download a past issue of R&D Pipeline News: Therapeutic Area Edition

The one-year subscriptions are available as single user license, departmental license, site license and global license. After completion of the purchase process, we will get in touch with you to gather the e-mail addresses of your institution for individual desktop delivery.
For further information please contact us at publishing@lamerie.com

Target Audience

  • R&D Professionals;
  • Consultants;
  • Competitive & Business Intelligence Professionals;
  • Scientific & Business Information Services;
  • Drug Delivery Technologists;
  • Project Leaders and Therapeutic Area Heads;
  • Business Development & Licensing;
  • Strategic Planning & Analysis;
  • Investment and Fonds Managers;
  • Technology & Regulatory Affaisrs Specialists;
  • Project & Product Developers;
  • R&D Directors and Managers;
  • Marketing & Sales;
  • Biomanufacturing & Operations;
  • Research Analysts.

Inside R&D Pipeline News

Tables with news described by:

  • Product Names;
  • Target / Mechanism of Action;
  • Class of Compound;
  • Company;
  • Therapeutic Area or Product Category;
  • Indication;
  • R&D stage;
  • Key message;
  • Hyperlink to original news document.

Company Profiles;
Featured Pipelines (Target, Technology, Indication);
Technology News;
R&D Collaboration Deals;
R&D Licensing Deals;
Mergers & Acquisitions

Source of Information

  • Company press releases;
  • Company reports;
  • Company homepages and presentations;
  • Databases and directories;
  • Business meetings & trade shows;
  • Regulatory Agencies;
  • Biotech & pharma organizations;
  • Scientific communications & publications,
  • Review articles;
  • Direct enquiries;
  • Disease & adacemic homepages;
  • Investor portfolios;
  • Internet monitoring.

The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up